nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—ALB—multiple sclerosis	0.143	1	CbGaD
Probenecid—ABCC11—Methotrexate—multiple sclerosis	0.093	0.135	CbGbCtD
Probenecid—SLC22A2—Cladribine—multiple sclerosis	0.047	0.0682	CbGbCtD
Probenecid—SLC22A1—Cladribine—multiple sclerosis	0.0408	0.0593	CbGbCtD
Probenecid—SLC16A1—Methotrexate—multiple sclerosis	0.0408	0.0592	CbGbCtD
Probenecid—SLCO1C1—Methotrexate—multiple sclerosis	0.0408	0.0592	CbGbCtD
Probenecid—ABCC1—Mitoxantrone—multiple sclerosis	0.0378	0.0549	CbGbCtD
Probenecid—SLCO1A2—Prednisolone—multiple sclerosis	0.0297	0.0431	CbGbCtD
Probenecid—SLCO1A2—Prednisone—multiple sclerosis	0.028	0.0407	CbGbCtD
Probenecid—ABCC3—Methotrexate—multiple sclerosis	0.0257	0.0373	CbGbCtD
Probenecid—SLC22A11—Methotrexate—multiple sclerosis	0.0211	0.0306	CbGbCtD
Probenecid—SLC22A7—Methotrexate—multiple sclerosis	0.0201	0.0291	CbGbCtD
Probenecid—ABCC4—Methotrexate—multiple sclerosis	0.0196	0.0285	CbGbCtD
Probenecid—SLCO1A2—Dexamethasone—multiple sclerosis	0.0175	0.0254	CbGbCtD
Probenecid—ABCC1—Methotrexate—multiple sclerosis	0.0157	0.0229	CbGbCtD
Probenecid—ABCC2—Dexamethasone—multiple sclerosis	0.0145	0.0211	CbGbCtD
Probenecid—ALB—Prednisone—multiple sclerosis	0.0145	0.021	CbGbCtD
Probenecid—SLCO1A2—Methotrexate—multiple sclerosis	0.0141	0.0204	CbGbCtD
Probenecid—ABCB1—Methylprednisolone—multiple sclerosis	0.0125	0.0182	CbGbCtD
Probenecid—SLC22A8—Methotrexate—multiple sclerosis	0.0122	0.0178	CbGbCtD
Probenecid—ABCC2—Methotrexate—multiple sclerosis	0.0117	0.0169	CbGbCtD
Probenecid—CYP3A4—Fingolimod—multiple sclerosis	0.0116	0.0169	CbGbCtD
Probenecid—CYP2C19—Prednisone—multiple sclerosis	0.00939	0.0136	CbGbCtD
Probenecid—ABCB1—Mitoxantrone—multiple sclerosis	0.00912	0.0132	CbGbCtD
Probenecid—SLC22A6—Methotrexate—multiple sclerosis	0.00853	0.0124	CbGbCtD
Probenecid—ABCB1—Betamethasone—multiple sclerosis	0.00813	0.0118	CbGbCtD
Probenecid—ABCB1—Prednisolone—multiple sclerosis	0.00802	0.0117	CbGbCtD
Probenecid—ABCB1—Prednisone—multiple sclerosis	0.00757	0.011	CbGbCtD
Probenecid—CYP3A4—Methylprednisolone—multiple sclerosis	0.00749	0.0109	CbGbCtD
Probenecid—ALB—Methotrexate—multiple sclerosis	0.00726	0.0106	CbGbCtD
Probenecid—CYP2C8—Dexamethasone—multiple sclerosis	0.00699	0.0101	CbGbCtD
Probenecid—CYP2C19—Dexamethasone—multiple sclerosis	0.00586	0.00851	CbGbCtD
Probenecid—CYP3A4—Triamcinolone—multiple sclerosis	0.00568	0.00825	CbGbCtD
Probenecid—CYP3A4—Mitoxantrone—multiple sclerosis	0.00546	0.00794	CbGbCtD
Probenecid—CYP2C9—Dexamethasone—multiple sclerosis	0.00487	0.00708	CbGbCtD
Probenecid—CYP3A4—Betamethasone—multiple sclerosis	0.00487	0.00707	CbGbCtD
Probenecid—CYP3A4—Prednisolone—multiple sclerosis	0.00481	0.00698	CbGbCtD
Probenecid—ABCB1—Dexamethasone—multiple sclerosis	0.00473	0.00687	CbGbCtD
Probenecid—CYP3A4—Prednisone—multiple sclerosis	0.00454	0.00659	CbGbCtD
Probenecid—ABCB1—Methotrexate—multiple sclerosis	0.0038	0.00552	CbGbCtD
Probenecid—CYP3A4—Dexamethasone—multiple sclerosis	0.00283	0.00412	CbGbCtD
Probenecid—Chlorpropamide—SLC15A2—multiple sclerosis	0.00153	0.339	CrCbGaD
Probenecid—Tolbutamide—SLC15A2—multiple sclerosis	0.00149	0.33	CrCbGaD
Probenecid—PANX1—spinal cord—multiple sclerosis	0.00138	0.0435	CbGeAlD
Probenecid—ABCC6—retina—multiple sclerosis	0.00118	0.0371	CbGeAlD
Probenecid—PANX1—nervous system—multiple sclerosis	0.00116	0.0366	CbGeAlD
Probenecid—PANX1—central nervous system—multiple sclerosis	0.00112	0.0352	CbGeAlD
Probenecid—PANX1—cerebellum—multiple sclerosis	0.00109	0.0345	CbGeAlD
Probenecid—Aplastic anaemia—Cladribine—multiple sclerosis	0.000991	0.0322	CcSEcCtD
Probenecid—Procaine—BCHE—multiple sclerosis	0.000982	0.218	CrCbGaD
Probenecid—PANX1—brain—multiple sclerosis	0.000886	0.028	CbGeAlD
Probenecid—Haemolytic anaemia—Cladribine—multiple sclerosis	0.000849	0.0276	CcSEcCtD
Probenecid—Alopecia—Fingolimod—multiple sclerosis	0.000827	0.0268	CcSEcCtD
Probenecid—SLC16A7—medulla oblongata—multiple sclerosis	0.000826	0.0261	CbGeAlD
Probenecid—Aplastic anaemia—Azathioprine—multiple sclerosis	0.000806	0.0262	CcSEcCtD
Probenecid—ABCC5—retina—multiple sclerosis	0.000799	0.0252	CbGeAlD
Probenecid—SLC16A7—midbrain—multiple sclerosis	0.000755	0.0238	CbGeAlD
Probenecid—Leukopenia—Fingolimod—multiple sclerosis	0.000729	0.0237	CcSEcCtD
Probenecid—SLC16A1—retina—multiple sclerosis	0.000727	0.023	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00069	0.0224	CcSEcCtD
Probenecid—SLCO1C1—midbrain—multiple sclerosis	0.000663	0.0209	CbGeAlD
Probenecid—SLCO1C1—spinal cord—multiple sclerosis	0.000647	0.0204	CbGeAlD
Probenecid—SLC16A7—nervous system—multiple sclerosis	0.00062	0.0196	CbGeAlD
Probenecid—SLC16A7—central nervous system—multiple sclerosis	0.000597	0.0189	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.000586	0.019	CcSEcCtD
Probenecid—SLC16A7—cerebellum—multiple sclerosis	0.000584	0.0184	CbGeAlD
Probenecid—SLC10A1—nervous system—multiple sclerosis	0.000579	0.0183	CbGeAlD
Probenecid—ABCC5—medulla oblongata—multiple sclerosis	0.000578	0.0182	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.000561	0.0182	CcSEcCtD
Probenecid—SLC10A1—central nervous system—multiple sclerosis	0.000558	0.0176	CbGeAlD
Probenecid—SLCO1C1—nervous system—multiple sclerosis	0.000545	0.0172	CbGeAlD
Probenecid—ABCC5—midbrain—multiple sclerosis	0.000528	0.0167	CbGeAlD
Probenecid—SLC16A1—medulla oblongata—multiple sclerosis	0.000526	0.0166	CbGeAlD
Probenecid—SLCO1C1—central nervous system—multiple sclerosis	0.000525	0.0166	CbGeAlD
Probenecid—Procainamide—BCHE—multiple sclerosis	0.000508	0.113	CrCbGaD
Probenecid—Erythema multiforme—Cladribine—multiple sclerosis	0.000501	0.0163	CcSEcCtD
Probenecid—SLC16A1—midbrain—multiple sclerosis	0.00048	0.0152	CbGeAlD
Probenecid—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000476	0.0155	CcSEcCtD
Probenecid—SLC16A7—brain—multiple sclerosis	0.000474	0.015	CbGeAlD
Probenecid—Pruritus—Fingolimod—multiple sclerosis	0.00047	0.0153	CcSEcCtD
Probenecid—SLC16A1—spinal cord—multiple sclerosis	0.000469	0.0148	CbGeAlD
Probenecid—Alopecia—Cladribine—multiple sclerosis	0.000469	0.0152	CcSEcCtD
Probenecid—SLC10A1—brain—multiple sclerosis	0.000443	0.014	CbGeAlD
Probenecid—Dizziness—Fingolimod—multiple sclerosis	0.000439	0.0143	CcSEcCtD
Probenecid—Anaemia—Cladribine—multiple sclerosis	0.000427	0.0138	CcSEcCtD
Probenecid—SLCO1C1—brain—multiple sclerosis	0.000416	0.0131	CbGeAlD
Probenecid—Headache—Fingolimod—multiple sclerosis	0.000416	0.0135	CcSEcCtD
Probenecid—SLCO1A2—medulla oblongata—multiple sclerosis	0.000416	0.0131	CbGeAlD
Probenecid—SLC22A5—retina—multiple sclerosis	0.000416	0.0131	CbGeAlD
Probenecid—ABCC5—cerebellum—multiple sclerosis	0.000409	0.0129	CbGeAlD
Probenecid—Erythema multiforme—Azathioprine—multiple sclerosis	0.000408	0.0132	CcSEcCtD
Probenecid—SLC16A1—nervous system—multiple sclerosis	0.000395	0.0125	CbGeAlD
Probenecid—SLC22A7—brain—multiple sclerosis	0.000395	0.0125	CbGeAlD
Probenecid—SLC22A6—brain—multiple sclerosis	0.000381	0.012	CbGeAlD
Probenecid—Alopecia—Azathioprine—multiple sclerosis	0.000381	0.0124	CcSEcCtD
Probenecid—SLCO1A2—midbrain—multiple sclerosis	0.00038	0.012	CbGeAlD
Probenecid—SLC16A1—central nervous system—multiple sclerosis	0.00038	0.012	CbGeAlD
Probenecid—SLC16A1—cerebellum—multiple sclerosis	0.000372	0.0117	CbGeAlD
Probenecid—SLCO1A2—spinal cord—multiple sclerosis	0.000371	0.0117	CbGeAlD
Probenecid—Haematuria—Mitoxantrone—multiple sclerosis	0.00037	0.012	CcSEcCtD
Probenecid—ABCC3—nervous system—multiple sclerosis	0.000365	0.0115	CbGeAlD
Probenecid—Anorexia—Cladribine—multiple sclerosis	0.000359	0.0117	CcSEcCtD
Probenecid—ABCC3—central nervous system—multiple sclerosis	0.000351	0.0111	CbGeAlD
Probenecid—Anaemia—Azathioprine—multiple sclerosis	0.000347	0.0113	CcSEcCtD
Probenecid—Leukopenia—Azathioprine—multiple sclerosis	0.000336	0.0109	CcSEcCtD
Probenecid—ABCC5—brain—multiple sclerosis	0.000332	0.0105	CbGeAlD
Probenecid—Decreased appetite—Cladribine—multiple sclerosis	0.000327	0.0106	CcSEcCtD
Probenecid—SLC22A1—nervous system—multiple sclerosis	0.000325	0.0103	CbGeAlD
Probenecid—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000325	0.0105	CcSEcCtD
Probenecid—Pain—Cladribine—multiple sclerosis	0.000322	0.0105	CcSEcCtD
Probenecid—SLCO1A2—nervous system—multiple sclerosis	0.000313	0.00987	CbGeAlD
Probenecid—SLC22A1—central nervous system—multiple sclerosis	0.000313	0.00987	CbGeAlD
Probenecid—Alopecia—Mitoxantrone—multiple sclerosis	0.000308	0.00999	CcSEcCtD
Probenecid—SLC16A1—brain—multiple sclerosis	0.000302	0.00953	CbGeAlD
Probenecid—SLCO1A2—central nervous system—multiple sclerosis	0.000301	0.0095	CbGeAlD
Probenecid—ABCC4—nervous system—multiple sclerosis	0.000301	0.0095	CbGeAlD
Probenecid—SLC22A5—medulla oblongata—multiple sclerosis	0.0003	0.00948	CbGeAlD
Probenecid—Urticaria—Cladribine—multiple sclerosis	0.000299	0.00971	CcSEcCtD
Probenecid—SLC22A8—nervous system—multiple sclerosis	0.000299	0.00942	CbGeAlD
Probenecid—Body temperature increased—Cladribine—multiple sclerosis	0.000298	0.00966	CcSEcCtD
Probenecid—SLCO1A2—cerebellum—multiple sclerosis	0.000294	0.00929	CbGeAlD
Probenecid—ABCC4—central nervous system—multiple sclerosis	0.00029	0.00915	CbGeAlD
Probenecid—SLC22A8—central nervous system—multiple sclerosis	0.000287	0.00907	CbGeAlD
Probenecid—Anaemia—Mitoxantrone—multiple sclerosis	0.00028	0.0091	CcSEcCtD
Probenecid—ABCC3—brain—multiple sclerosis	0.000279	0.0088	CbGeAlD
Probenecid—Hypersensitivity—Cladribine—multiple sclerosis	0.000278	0.00901	CcSEcCtD
Probenecid—SLC22A5—midbrain—multiple sclerosis	0.000274	0.00866	CbGeAlD
Probenecid—Leukopenia—Mitoxantrone—multiple sclerosis	0.000272	0.00881	CcSEcCtD
Probenecid—SLC22A5—spinal cord—multiple sclerosis	0.000268	0.00845	CbGeAlD
Probenecid—Pruritus—Cladribine—multiple sclerosis	0.000267	0.00865	CcSEcCtD
Probenecid—Dizziness—Cladribine—multiple sclerosis	0.000249	0.00808	CcSEcCtD
Probenecid—SLC22A1—brain—multiple sclerosis	0.000248	0.00783	CbGeAlD
Probenecid—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000248	0.00804	CcSEcCtD
Probenecid—Body temperature increased—Azathioprine—multiple sclerosis	0.000242	0.00786	CcSEcCtD
Probenecid—ABCC1—cerebellum—multiple sclerosis	0.000241	0.00762	CbGeAlD
Probenecid—Vomiting—Cladribine—multiple sclerosis	0.00024	0.00777	CcSEcCtD
Probenecid—SLCO1A2—brain—multiple sclerosis	0.000239	0.00754	CbGeAlD
Probenecid—ALB—brain—multiple sclerosis	0.000238	0.0075	CbGeAlD
Probenecid—Dermatitis—Cladribine—multiple sclerosis	0.000237	0.0077	CcSEcCtD
Probenecid—Anorexia—Mitoxantrone—multiple sclerosis	0.000236	0.00766	CcSEcCtD
Probenecid—Headache—Cladribine—multiple sclerosis	0.000236	0.00766	CcSEcCtD
Probenecid—ABCC4—brain—multiple sclerosis	0.00023	0.00726	CbGeAlD
Probenecid—SLC22A8—brain—multiple sclerosis	0.000228	0.0072	CbGeAlD
Probenecid—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000226	0.00734	CcSEcCtD
Probenecid—Hypersensitivity—Azathioprine—multiple sclerosis	0.000226	0.00732	CcSEcCtD
Probenecid—Nausea—Cladribine—multiple sclerosis	0.000224	0.00726	CcSEcCtD
Probenecid—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000215	0.00699	CcSEcCtD
Probenecid—SLC22A5—cerebellum—multiple sclerosis	0.000212	0.0067	CbGeAlD
Probenecid—Pain—Mitoxantrone—multiple sclerosis	0.000212	0.00687	CcSEcCtD
Probenecid—Alopecia—Betamethasone—multiple sclerosis	0.000211	0.00684	CcSEcCtD
Probenecid—Alopecia—Dexamethasone—multiple sclerosis	0.000211	0.00684	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000203	0.00659	CcSEcCtD
Probenecid—Dizziness—Azathioprine—multiple sclerosis	0.000203	0.00657	CcSEcCtD
Probenecid—Urticaria—Mitoxantrone—multiple sclerosis	0.000197	0.00638	CcSEcCtD
Probenecid—ABCC1—brain—multiple sclerosis	0.000196	0.00619	CbGeAlD
Probenecid—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000196	0.00635	CcSEcCtD
Probenecid—Vomiting—Azathioprine—multiple sclerosis	0.000195	0.00632	CcSEcCtD
Probenecid—Dermatitis—Azathioprine—multiple sclerosis	0.000193	0.00626	CcSEcCtD
Probenecid—ABCB1—retina—multiple sclerosis	0.000193	0.00609	CbGeAlD
Probenecid—Flushing—Prednisone—multiple sclerosis	0.000193	0.00626	CcSEcCtD
Probenecid—Headache—Azathioprine—multiple sclerosis	0.000192	0.00623	CcSEcCtD
Probenecid—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000192	0.00622	CcSEcCtD
Probenecid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000187	0.00606	CcSEcCtD
Probenecid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000186	0.00605	CcSEcCtD
Probenecid—Haematuria—Methotrexate—multiple sclerosis	0.000184	0.00599	CcSEcCtD
Probenecid—Alopecia—Prednisone—multiple sclerosis	0.000184	0.00596	CcSEcCtD
Probenecid—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000182	0.00592	CcSEcCtD
Probenecid—Nausea—Azathioprine—multiple sclerosis	0.000182	0.0059	CcSEcCtD
Probenecid—Pain—Prednisolone—multiple sclerosis	0.000174	0.00564	CcSEcCtD
Probenecid—SLC22A5—brain—multiple sclerosis	0.000172	0.00544	CbGeAlD
Probenecid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000169	0.0055	CcSEcCtD
Probenecid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000169	0.0055	CcSEcCtD
Probenecid—Anaemia—Prednisone—multiple sclerosis	0.000167	0.00543	CcSEcCtD
Probenecid—CYP2C8—brain—multiple sclerosis	0.000167	0.00527	CbGeAlD
Probenecid—Erythema multiforme—Methotrexate—multiple sclerosis	0.000164	0.00533	CcSEcCtD
Probenecid—Anorexia—Dexamethasone—multiple sclerosis	0.000162	0.00524	CcSEcCtD
Probenecid—Anorexia—Betamethasone—multiple sclerosis	0.000162	0.00524	CcSEcCtD
Probenecid—Urticaria—Prednisolone—multiple sclerosis	0.000161	0.00524	CcSEcCtD
Probenecid—Pain—Triamcinolone—multiple sclerosis	0.00016	0.00518	CcSEcCtD
Probenecid—Vomiting—Mitoxantrone—multiple sclerosis	0.000157	0.00511	CcSEcCtD
Probenecid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000156	0.00506	CcSEcCtD
Probenecid—Headache—Mitoxantrone—multiple sclerosis	0.000155	0.00503	CcSEcCtD
Probenecid—Alopecia—Methotrexate—multiple sclerosis	0.000153	0.00498	CcSEcCtD
Probenecid—Hypersensitivity—Prednisolone—multiple sclerosis	0.00015	0.00486	CcSEcCtD
Probenecid—Urticaria—Triamcinolone—multiple sclerosis	0.000148	0.00482	CcSEcCtD
Probenecid—Urticaria—Methylprednisolone—multiple sclerosis	0.000148	0.00481	CcSEcCtD
Probenecid—CYP3A4—nervous system—multiple sclerosis	0.000148	0.00467	CbGeAlD
Probenecid—Body temperature increased—Triamcinolone—multiple sclerosis	0.000148	0.00479	CcSEcCtD
Probenecid—Anaphylactic shock—Prednisone—multiple sclerosis	0.000148	0.00479	CcSEcCtD
Probenecid—Decreased appetite—Betamethasone—multiple sclerosis	0.000147	0.00478	CcSEcCtD
Probenecid—Decreased appetite—Dexamethasone—multiple sclerosis	0.000147	0.00478	CcSEcCtD
Probenecid—Nausea—Mitoxantrone—multiple sclerosis	0.000147	0.00477	CcSEcCtD
Probenecid—Pain—Dexamethasone—multiple sclerosis	0.000145	0.0047	CcSEcCtD
Probenecid—Pain—Betamethasone—multiple sclerosis	0.000145	0.0047	CcSEcCtD
Probenecid—CYP3A4—central nervous system—multiple sclerosis	0.000142	0.0045	CbGeAlD
Probenecid—Anorexia—Prednisone—multiple sclerosis	0.000141	0.00457	CcSEcCtD
Probenecid—Anaemia—Methotrexate—multiple sclerosis	0.00014	0.00453	CcSEcCtD
Probenecid—ABCB1—medulla oblongata—multiple sclerosis	0.000139	0.0044	CbGeAlD
Probenecid—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000138	0.00447	CcSEcCtD
Probenecid—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000137	0.00446	CcSEcCtD
Probenecid—Leukopenia—Methotrexate—multiple sclerosis	0.000135	0.00439	CcSEcCtD
Probenecid—Urticaria—Betamethasone—multiple sclerosis	0.000135	0.00437	CcSEcCtD
Probenecid—Urticaria—Dexamethasone—multiple sclerosis	0.000135	0.00437	CcSEcCtD
Probenecid—Dizziness—Prednisolone—multiple sclerosis	0.000134	0.00436	CcSEcCtD
Probenecid—Body temperature increased—Dexamethasone—multiple sclerosis	0.000134	0.00435	CcSEcCtD
Probenecid—Body temperature increased—Betamethasone—multiple sclerosis	0.000134	0.00435	CcSEcCtD
Probenecid—Pruritus—Triamcinolone—multiple sclerosis	0.000132	0.00429	CcSEcCtD
Probenecid—Pruritus—Methylprednisolone—multiple sclerosis	0.000132	0.00428	CcSEcCtD
Probenecid—Decreased appetite—Prednisone—multiple sclerosis	0.000128	0.00416	CcSEcCtD
Probenecid—Dermatitis—Prednisolone—multiple sclerosis	0.000128	0.00415	CcSEcCtD
Probenecid—ABCB1—midbrain—multiple sclerosis	0.000127	0.00402	CbGeAlD
Probenecid—Headache—Prednisolone—multiple sclerosis	0.000127	0.00413	CcSEcCtD
Probenecid—ABCB1—spinal cord—multiple sclerosis	0.000124	0.00392	CbGeAlD
Probenecid—Dizziness—Triamcinolone—multiple sclerosis	0.000124	0.00401	CcSEcCtD
Probenecid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000123	0.004	CcSEcCtD
Probenecid—Dizziness—Methylprednisolone—multiple sclerosis	0.000123	0.004	CcSEcCtD
Probenecid—Nausea—Prednisolone—multiple sclerosis	0.000121	0.00392	CcSEcCtD
Probenecid—Pruritus—Betamethasone—multiple sclerosis	0.00012	0.00389	CcSEcCtD
Probenecid—Pruritus—Dexamethasone—multiple sclerosis	0.00012	0.00389	CcSEcCtD
Probenecid—Vomiting—Triamcinolone—multiple sclerosis	0.000119	0.00385	CcSEcCtD
Probenecid—Vomiting—Methylprednisolone—multiple sclerosis	0.000119	0.00385	CcSEcCtD
Probenecid—Dermatitis—Triamcinolone—multiple sclerosis	0.000118	0.00382	CcSEcCtD
Probenecid—Anorexia—Methotrexate—multiple sclerosis	0.000118	0.00382	CcSEcCtD
Probenecid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000117	0.00381	CcSEcCtD
Probenecid—Urticaria—Prednisone—multiple sclerosis	0.000117	0.00381	CcSEcCtD
Probenecid—Headache—Triamcinolone—multiple sclerosis	0.000117	0.0038	CcSEcCtD
Probenecid—Headache—Methylprednisolone—multiple sclerosis	0.000117	0.00379	CcSEcCtD
Probenecid—Body temperature increased—Prednisone—multiple sclerosis	0.000117	0.00379	CcSEcCtD
Probenecid—Dizziness—Dexamethasone—multiple sclerosis	0.000112	0.00364	CcSEcCtD
Probenecid—Dizziness—Betamethasone—multiple sclerosis	0.000112	0.00364	CcSEcCtD
Probenecid—Nausea—Triamcinolone—multiple sclerosis	0.000111	0.0036	CcSEcCtD
Probenecid—Nausea—Methylprednisolone—multiple sclerosis	0.000111	0.00359	CcSEcCtD
Probenecid—Hypersensitivity—Prednisone—multiple sclerosis	0.000109	0.00353	CcSEcCtD
Probenecid—Vomiting—Dexamethasone—multiple sclerosis	0.000108	0.0035	CcSEcCtD
Probenecid—Vomiting—Betamethasone—multiple sclerosis	0.000108	0.0035	CcSEcCtD
Probenecid—Decreased appetite—Methotrexate—multiple sclerosis	0.000107	0.00348	CcSEcCtD
Probenecid—Dermatitis—Dexamethasone—multiple sclerosis	0.000107	0.00347	CcSEcCtD
Probenecid—Dermatitis—Betamethasone—multiple sclerosis	0.000107	0.00347	CcSEcCtD
Probenecid—Headache—Betamethasone—multiple sclerosis	0.000106	0.00345	CcSEcCtD
Probenecid—Headache—Dexamethasone—multiple sclerosis	0.000106	0.00345	CcSEcCtD
Probenecid—Pain—Methotrexate—multiple sclerosis	0.000105	0.00342	CcSEcCtD
Probenecid—ABCB1—nervous system—multiple sclerosis	0.000105	0.00331	CbGeAlD
Probenecid—Pruritus—Prednisone—multiple sclerosis	0.000104	0.00339	CcSEcCtD
Probenecid—ABCB1—central nervous system—multiple sclerosis	0.000101	0.00318	CbGeAlD
Probenecid—Nausea—Betamethasone—multiple sclerosis	0.000101	0.00327	CcSEcCtD
Probenecid—Nausea—Dexamethasone—multiple sclerosis	0.000101	0.00327	CcSEcCtD
Probenecid—ABCB1—cerebellum—multiple sclerosis	9.86e-05	0.00311	CbGeAlD
Probenecid—Urticaria—Methotrexate—multiple sclerosis	9.8e-05	0.00318	CcSEcCtD
Probenecid—Dizziness—Prednisone—multiple sclerosis	9.76e-05	0.00317	CcSEcCtD
Probenecid—Body temperature increased—Methotrexate—multiple sclerosis	9.75e-05	0.00316	CcSEcCtD
Probenecid—Vomiting—Prednisone—multiple sclerosis	9.39e-05	0.00305	CcSEcCtD
Probenecid—Dermatitis—Prednisone—multiple sclerosis	9.3e-05	0.00302	CcSEcCtD
Probenecid—Headache—Prednisone—multiple sclerosis	9.25e-05	0.003	CcSEcCtD
Probenecid—Hypersensitivity—Methotrexate—multiple sclerosis	9.09e-05	0.00295	CcSEcCtD
Probenecid—Nausea—Prednisone—multiple sclerosis	8.77e-05	0.00285	CcSEcCtD
Probenecid—Pruritus—Methotrexate—multiple sclerosis	8.73e-05	0.00283	CcSEcCtD
Probenecid—Dizziness—Methotrexate—multiple sclerosis	8.16e-05	0.00265	CcSEcCtD
Probenecid—ABCB1—brain—multiple sclerosis	8.01e-05	0.00253	CbGeAlD
Probenecid—Vomiting—Methotrexate—multiple sclerosis	7.84e-05	0.00255	CcSEcCtD
Probenecid—Dermatitis—Methotrexate—multiple sclerosis	7.77e-05	0.00252	CcSEcCtD
Probenecid—Headache—Methotrexate—multiple sclerosis	7.73e-05	0.00251	CcSEcCtD
Probenecid—Nausea—Methotrexate—multiple sclerosis	7.33e-05	0.00238	CcSEcCtD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.45e-05	0.00034	CbGpPWpGaD
Probenecid—ABCC1—Disease—GPC5—multiple sclerosis	3.45e-05	0.00034	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PLEK—multiple sclerosis	3.45e-05	0.00034	CbGpPWpGaD
Probenecid—ABCC4—Ectoderm Differentiation—MYC—multiple sclerosis	3.44e-05	0.000339	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.43e-05	0.000338	CbGpPWpGaD
Probenecid—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.4e-05	0.000336	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.35e-05	0.000331	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.34e-05	0.00033	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.28e-05	0.000324	CbGpPWpGaD
Probenecid—PANX1—Immune System—STAT3—multiple sclerosis	3.28e-05	0.000323	CbGpPWpGaD
Probenecid—ABCC4—NRF2 pathway—TGFB1—multiple sclerosis	3.28e-05	0.000323	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	3.21e-05	0.000317	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—GPC5—multiple sclerosis	3.21e-05	0.000317	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	3.21e-05	0.000316	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.16e-05	0.000311	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.16e-05	0.000311	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.15e-05	0.000311	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.15e-05	0.000311	CbGpPWpGaD
Probenecid—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.12e-05	0.000308	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.12e-05	0.000307	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—BCHE—multiple sclerosis	3.1e-05	0.000306	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.09e-05	0.000304	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.06e-05	0.000302	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—RRM1—multiple sclerosis	3.05e-05	0.000301	CbGpPWpGaD
Probenecid—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.02e-05	0.000298	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.01e-05	0.000297	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.98e-05	0.000294	CbGpPWpGaD
Probenecid—PANX1—Immune System—MAPK1—multiple sclerosis	2.98e-05	0.000294	CbGpPWpGaD
Probenecid—ABCC5—Disease—CD28—multiple sclerosis	2.97e-05	0.000293	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—GPC5—multiple sclerosis	2.89e-05	0.000285	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.86e-05	0.000282	CbGpPWpGaD
Probenecid—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.84e-05	0.00028	CbGpPWpGaD
Probenecid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.83e-05	0.000279	CbGpPWpGaD
Probenecid—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	2.76e-05	0.000272	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	2.75e-05	0.000271	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	2.75e-05	0.000271	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	2.73e-05	0.000269	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—IL2—multiple sclerosis	2.72e-05	0.000268	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.69e-05	0.000266	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—RRM1—multiple sclerosis	2.66e-05	0.000262	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—IL2RA—multiple sclerosis	2.65e-05	0.000261	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.61e-05	0.000258	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—TNF—multiple sclerosis	2.61e-05	0.000258	CbGpPWpGaD
Probenecid—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.59e-05	0.000256	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—ALB—multiple sclerosis	2.57e-05	0.000253	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP27B1—multiple sclerosis	2.56e-05	0.000253	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—CYP24A1—multiple sclerosis	2.56e-05	0.000253	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—GPC5—multiple sclerosis	2.51e-05	0.000248	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—SRM—multiple sclerosis	2.45e-05	0.000241	CbGpPWpGaD
Probenecid—ALB—Metabolism—SRM—multiple sclerosis	2.43e-05	0.00024	CbGpPWpGaD
Probenecid—ALB—Hemostasis—SELE—multiple sclerosis	2.43e-05	0.00024	CbGpPWpGaD
Probenecid—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.4e-05	0.000237	CbGpPWpGaD
Probenecid—ABCC5—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.39e-05	0.000236	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—RRM1—multiple sclerosis	2.39e-05	0.000236	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—BCHE—multiple sclerosis	2.38e-05	0.000235	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.37e-05	0.000234	CbGpPWpGaD
Probenecid—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.37e-05	0.000234	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.36e-05	0.000233	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.35e-05	0.000232	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—GPC5—multiple sclerosis	2.34e-05	0.000231	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.33e-05	0.000229	CbGpPWpGaD
Probenecid—ABCC4—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.31e-05	0.000227	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.3e-05	0.000227	CbGpPWpGaD
Probenecid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.29e-05	0.000226	CbGpPWpGaD
Probenecid—PANX1—Immune System—IL6—multiple sclerosis	2.29e-05	0.000226	CbGpPWpGaD
Probenecid—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2.29e-05	0.000225	CbGpPWpGaD
Probenecid—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.27e-05	0.000224	CbGpPWpGaD
Probenecid—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.27e-05	0.000224	CbGpPWpGaD
Probenecid—ABCC1—Disease—RPL5—multiple sclerosis	2.24e-05	0.000221	CbGpPWpGaD
Probenecid—SLC16A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.22e-05	0.000219	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—BCHE—multiple sclerosis	2.21e-05	0.000218	CbGpPWpGaD
Probenecid—SLC22A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.21e-05	0.000218	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—SRM—multiple sclerosis	2.18e-05	0.000215	CbGpPWpGaD
Probenecid—ABCC1—Disease—SLC11A1—multiple sclerosis	2.15e-05	0.000212	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—SRM—multiple sclerosis	2.13e-05	0.00021	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.12e-05	0.000209	CbGpPWpGaD
Probenecid—ABCC5—Disease—CD86—multiple sclerosis	2.12e-05	0.000209	CbGpPWpGaD
Probenecid—ALB—Folate Metabolism—IL6—multiple sclerosis	2.11e-05	0.000208	CbGpPWpGaD
Probenecid—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.08e-05	0.000206	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—IL2—multiple sclerosis	2.08e-05	0.000206	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—RRM1—multiple sclerosis	2.08e-05	0.000206	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	2.08e-05	0.000205	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.07e-05	0.000204	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.06e-05	0.000203	CbGpPWpGaD
Probenecid—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.06e-05	0.000203	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.04e-05	0.000201	CbGpPWpGaD
Probenecid—CYP2C19—Biological oxidations—POMC—multiple sclerosis	2.02e-05	0.0002	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SRM—multiple sclerosis	1.99e-05	0.000196	CbGpPWpGaD
Probenecid—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.98e-05	0.000196	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—RRM1—multiple sclerosis	1.94e-05	0.000192	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—ALB—multiple sclerosis	1.92e-05	0.000189	CbGpPWpGaD
Probenecid—SLC22A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.91e-05	0.000189	CbGpPWpGaD
Probenecid—ABCC5—Disease—CCR5—multiple sclerosis	1.88e-05	0.000185	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—APOE—multiple sclerosis	1.87e-05	0.000184	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.86e-05	0.000183	CbGpPWpGaD
Probenecid—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.86e-05	0.000183	CbGpPWpGaD
Probenecid—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.85e-05	0.000182	CbGpPWpGaD
Probenecid—ABCC5—Disease—HLA-A—multiple sclerosis	1.83e-05	0.000181	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.83e-05	0.00018	CbGpPWpGaD
Probenecid—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.81e-05	0.000179	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.77e-05	0.000175	CbGpPWpGaD
Probenecid—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.76e-05	0.000174	CbGpPWpGaD
Probenecid—ALB—Hemostasis—ITGA4—multiple sclerosis	1.76e-05	0.000173	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000173	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IFNB1—multiple sclerosis	1.74e-05	0.000172	CbGpPWpGaD
Probenecid—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.73e-05	0.000171	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.72e-05	0.00017	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.72e-05	0.00017	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD28—multiple sclerosis	1.71e-05	0.000169	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP24A1—multiple sclerosis	1.71e-05	0.000169	CbGpPWpGaD
Probenecid—ALB—Metabolism—CYP27B1—multiple sclerosis	1.71e-05	0.000169	CbGpPWpGaD
Probenecid—ABCC5—Disease—APOE—multiple sclerosis	1.71e-05	0.000169	CbGpPWpGaD
Probenecid—SLC22A1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.69e-05	0.000167	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.69e-05	0.000166	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.68e-05	0.000165	CbGpPWpGaD
Probenecid—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.67e-05	0.000165	CbGpPWpGaD
Probenecid—ABCC4—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.66e-05	0.000164	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—TGFB1—multiple sclerosis	1.63e-05	0.00016	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.62e-05	0.000159	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—POMC—multiple sclerosis	1.6e-05	0.000158	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.59e-05	0.000157	CbGpPWpGaD
Probenecid—SLC16A1—Hemostasis—MAPK1—multiple sclerosis	1.59e-05	0.000157	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.58e-05	0.000156	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPC5—multiple sclerosis	1.57e-05	0.000155	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—IL2—multiple sclerosis	1.55e-05	0.000153	CbGpPWpGaD
Probenecid—ABCC5—Disease—CD80—multiple sclerosis	1.55e-05	0.000152	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.54e-05	0.000152	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.54e-05	0.000152	CbGpPWpGaD
Probenecid—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.54e-05	0.000152	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.53e-05	0.000151	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.5e-05	0.000148	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.5e-05	0.000148	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.5e-05	0.000148	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—ALB—multiple sclerosis	1.46e-05	0.000144	CbGpPWpGaD
Probenecid—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.45e-05	0.000143	CbGpPWpGaD
Probenecid—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.44e-05	0.000142	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—APOE—multiple sclerosis	1.43e-05	0.000141	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.41e-05	0.000139	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.4e-05	0.000138	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.4e-05	0.000138	CbGpPWpGaD
Probenecid—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.000138	CbGpPWpGaD
Probenecid—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	1.39e-05	0.000137	CbGpPWpGaD
Probenecid—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.38e-05	0.000136	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—BCHE—multiple sclerosis	1.37e-05	0.000136	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPC5—multiple sclerosis	1.37e-05	0.000135	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.37e-05	0.000135	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.36e-05	0.000135	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—APOE—multiple sclerosis	1.33e-05	0.000131	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SRM—multiple sclerosis	1.31e-05	0.00013	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.31e-05	0.000129	CbGpPWpGaD
Probenecid—ABCC5—Disease—TYK2—multiple sclerosis	1.3e-05	0.000129	CbGpPWpGaD
Probenecid—ALB—Metabolism—RRM1—multiple sclerosis	1.3e-05	0.000128	CbGpPWpGaD
Probenecid—SLC22A1—Neuronal System—MAPK1—multiple sclerosis	1.29e-05	0.000128	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.28e-05	0.000127	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—POMC—multiple sclerosis	1.23e-05	0.000121	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD86—multiple sclerosis	1.22e-05	0.000121	CbGpPWpGaD
Probenecid—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.22e-05	0.00012	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—TGFB1—multiple sclerosis	1.21e-05	0.00012	CbGpPWpGaD
Probenecid—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-05	0.000119	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2RA—multiple sclerosis	1.2e-05	0.000118	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—BCHE—multiple sclerosis	1.2e-05	0.000118	CbGpPWpGaD
Probenecid—ABCC4—Hemostasis—MAPK1—multiple sclerosis	1.19e-05	0.000117	CbGpPWpGaD
Probenecid—ABCC5—Disease—CD4—multiple sclerosis	1.18e-05	0.000116	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.17e-05	0.000115	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—POMC—multiple sclerosis	1.14e-05	0.000113	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000112	CbGpPWpGaD
Probenecid—SLC22A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.12e-05	0.000111	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—ALB—multiple sclerosis	1.12e-05	0.000111	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—BCHE—multiple sclerosis	1.12e-05	0.00011	CbGpPWpGaD
Probenecid—ABCC1—Disease—CCR5—multiple sclerosis	1.09e-05	0.000107	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	1.06e-05	0.000105	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.06e-05	0.000105	CbGpPWpGaD
Probenecid—ABCC1—Disease—HLA-A—multiple sclerosis	1.06e-05	0.000104	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—APOE—multiple sclerosis	1.06e-05	0.000104	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.05e-05	0.000104	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.05e-05	0.000103	CbGpPWpGaD
Probenecid—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	1.04e-05	0.000103	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—ALB—multiple sclerosis	1.04e-05	0.000103	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.03e-05	0.000101	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.01e-05	0.0001	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.01e-05	9.94e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—APOE—multiple sclerosis	9.87e-06	9.74e-05	CbGpPWpGaD
Probenecid—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	9.78e-06	9.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	9.25e-06	9.13e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	9.25e-06	9.13e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—APOE—multiple sclerosis	9.19e-06	9.06e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—STAT3—multiple sclerosis	9.13e-06	9.01e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—POMC—multiple sclerosis	9.06e-06	8.94e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.05e-06	8.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD80—multiple sclerosis	8.93e-06	8.8e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.71e-06	8.59e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	8.66e-06	8.54e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MYC—multiple sclerosis	8.49e-06	8.37e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—TGFB1—multiple sclerosis	8.47e-06	8.35e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPC5—multiple sclerosis	8.46e-06	8.35e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—MAPK1—multiple sclerosis	8.3e-06	8.19e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—APOE—multiple sclerosis	8.27e-06	8.15e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—ALB—multiple sclerosis	8.26e-06	8.15e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.25e-06	8.14e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.94e-06	7.83e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—POMC—multiple sclerosis	7.89e-06	7.78e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.77e-06	7.67e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TYK2—multiple sclerosis	7.53e-06	7.43e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—BCHE—multiple sclerosis	7.5e-06	7.4e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—BCHE—multiple sclerosis	7.46e-06	7.36e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—APOE—multiple sclerosis	7.2e-06	7.1e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—ALB—multiple sclerosis	7.2e-06	7.1e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—POMC—multiple sclerosis	7.1e-06	7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.09e-06	6.99e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.09e-06	6.99e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—IL2—multiple sclerosis	7.03e-06	6.94e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.01e-06	6.92e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—CD4—multiple sclerosis	6.81e-06	6.72e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—multiple sclerosis	6.71e-06	6.62e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.7e-06	6.61e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.58e-06	6.49e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—BCHE—multiple sclerosis	6.54e-06	6.45e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—multiple sclerosis	6.47e-06	6.39e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.46e-06	6.37e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—multiple sclerosis	6.38e-06	6.29e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—POMC—multiple sclerosis	6.18e-06	6.1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—BCHE—multiple sclerosis	6.11e-06	6.02e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—POMC—multiple sclerosis	5.76e-06	5.69e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—multiple sclerosis	5.64e-06	5.56e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—multiple sclerosis	5.48e-06	5.41e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK1—multiple sclerosis	5.38e-06	5.31e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—STAT3—multiple sclerosis	5.28e-06	5.2e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—multiple sclerosis	5.26e-06	5.18e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MYC—multiple sclerosis	4.9e-06	4.84e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—multiple sclerosis	4.89e-06	4.82e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK1—multiple sclerosis	4.8e-06	4.73e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—multiple sclerosis	4.51e-06	4.45e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—multiple sclerosis	4.49e-06	4.43e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—multiple sclerosis	4.03e-06	3.97e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.03e-06	3.97e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—multiple sclerosis	3.93e-06	3.88e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POMC—multiple sclerosis	3.88e-06	3.83e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—POMC—multiple sclerosis	3.86e-06	3.8e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—multiple sclerosis	3.69e-06	3.63e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—multiple sclerosis	3.67e-06	3.62e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—multiple sclerosis	3.54e-06	3.49e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POMC—multiple sclerosis	3.46e-06	3.41e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POMC—multiple sclerosis	3.38e-06	3.33e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POMC—multiple sclerosis	3.16e-06	3.11e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—multiple sclerosis	3.16e-06	3.11e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—multiple sclerosis	3.08e-06	3.04e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—multiple sclerosis	2.88e-06	2.84e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—multiple sclerosis	2.42e-06	2.39e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POMC—multiple sclerosis	2.08e-06	2.05e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—multiple sclerosis	1.9e-06	1.87e-05	CbGpPWpGaD
